FONR
Fonar Corporation
NASDAQ: FONR · HEALTHCARE · DIAGNOSTICS & RESEARCH
$18.86
-0.10% today
Updated 2026-06-02
Market cap
$120.20M
P/E ratio
19.09
P/S ratio
1.14x
EPS (TTM)
$1.00
Dividend yield
—
52W range
$14 – $19
Volume
0.1M
WallStSmart proprietary scores
38
out of 100
Grade: D
Sell
Investment rating
2.7
Growth
F8.5
Quality
A4.5
Profitability
C4.3
Valuation
C3/9
Piotroski F-Score
Weak
3.0
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$11.78
-37.54%
12-Month target
$11.78
-37.54%
Intrinsic (DCF)
$14.65
Margin of safety
-26.83%
Price chart
Stock snapshot
Strengths
+ Altman Z 3.02 — safe zone
+ Free cash flow $1.41M — positive
+ Debt/equity 0.22x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Revenue declining -2.60% QoQ
- 26.83% above intrinsic value
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $97.59M | $98.65M | $102.88M | $104.35M | $105.34M |
| Net income | $12.44M | $9.38M | $10.57M | $8.33M | $1.64M |
| EPS | — | — | — | — | $1.00 |
| Free cash flow | $10.67M | $10.13M | $13.27M | $7.45M | $1.41M |
| Profit margin | 12.75% | 9.50% | 10.27% | 7.99% | 6.35% |
Peer comparison
Smart narrative
Fonar Corporation trades at $18.86. representing a P/E of 19.09x trailing earnings. Our Smart Value Score of 38/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 3.02, it sits in the safe zone. TTM revenue stands at $105.34M. with profit margins at 6.35%. Our DCF model estimates intrinsic value at $14.65.
Frequently asked questions
What is Fonar Corporation's stock price?
Fonar Corporation (FONR) trades at $18.86, on a P/E of 19.1x and a P/S of 1.1x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Fonar Corporation overvalued?
Fonar Corporation carries a Smart Value Score of 38/100 (Grade D), which we rate Sell. That score blends growth, quality, and valuation into one read. On valuation specifically, our conservative DCF puts intrinsic value at $14.65 against the $18.86 price, so on cash flow terms the market is paying a premium for Fonar Corporation's growth. The Sell rating reflects that growth and quality, while the DCF flags that the price already assumes a lot.
What is the price target of Fonar Corporation (FONR)?
The 12-month analyst consensus target is $11.78, about 37.5% below the current $18.86. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the intrinsic value of Fonar Corporation (FONR)?
Our DCF model estimates intrinsic value at $14.65, a -26.8% margin of safety versus today's $18.86. Intrinsic value is what the projected cash flows are worth today. A negative reading means the price is running ahead of that conservative estimate, leaving little downside cushion if growth slows.
What is Fonar Corporation's revenue?
Fonar Corporation's trailing twelve-month revenue is $105.34M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Fonar Corporation's Altman Z-Score is 3.02, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryDIAGNOSTICS & RESEARCH
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1.14x
ROE5.47%
Beta0.96
50D MA$18.81
200D MA$17.02
Shares out0.01B
Float0.01B
Short ratio—
Avg volume0.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—